FDA Approved: STRIVERDI RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Striverdi Respimat (olodaterol inhalation spray) as an original application from Boehringer Ingelheim for the treatment of chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Striverdi Respimat (olodaterol)

Snippet

ORIG AP for STRIVERDI RESPIMAT (OLODATEROL RESPIMAT INHALATION SPRAY)